Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human phase I/II trial of topical BEN2293 in mild to moderate atopic dermatitis
MOH_2022-10-25_012077Phase 2Not yet recruiting
- Sponsor
- BenevolentAI
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing BEN2293 with Placebo ointment (2 arms). Planned start Sep 2022; status: not yet recruiting.
02
Drugs
BEN-2293
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on MOH_2022-10-25_012077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-10-25_012077.